Search Results

On the heels of its top “three-star” rating from the Society of Thoracic Surgeons, a repeat “Best Children’s Hospital” designation, and its ranking among the nation’s top Pediatric Heart Centers from U.S. News & World Report, Phoenix Children’s will open a newly expanded Cardiovascular Intensive Care Unit (CVICU) in July 2019. With 48 total inpatient beds, the new CVICU doubles the capacity of the previous 24-bed unit. New CVICU rooms are equipped with state-of-the-art technology like surgical lighting, lifts for mobilizing adult patients and improved monitoring capabilities.

Nationally ranked pediatric leader, Phoenix Children’s Hospital, is the first-ever health system in the U.S. to receive and deploy the newly FDA-cleared Medtronic Stealth Autoguide™ platform. Medtronic, a global leader in medical technology, chose Barrow Neurological Institute (BNI) at Phoenix Children’s as its first partner using this robotic technology. The highly advanced surgical tool is intended for use with the Medtronic StealthStation™ system, and Phoenix Children’s Hospital will use it in surgery for pediatric patients suffering from a range of neurological conditions.

The 39 experienced pediatric anesthesiologists have practiced extensively at Phoenix Children’s and will now be directly employed by Phoenix Children’s Medical Group.

Highlighting its nationally recognized achievements in patient safety and quality, Phoenix Children's Hospital was named a Top Children's Hospital by The Leapfrog Group for the fourth time. Announced today, the Leapfrog Top Hospital award is widely acknowledged as one of the most competitive honors American hospitals can receive. The Top Hospital designation is awarded by The Leapfrog Group, an independent hospital watchdog organization.

In a move to further enhance the award-winning health system’s ability to provide specialized care for children at high risk of infection, Phoenix Children’s created a new Division of Infectious Diseases and named Wassim Ballan, MD, chief of the division.